Role of Exogenous Hsp72 on Liver Dysfunction during Sepsis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Tsai, Tsen Ni ^a   Ho, Jia Jing ^a   Liu, Maw Shung ^a,b   Lee, Tzu Ying ^a   Lu, Mei Chin ^c   Liu, Chia Jen ^a   Huang, Li Ju ^d   Lue, Sheng I ^b   Yang, Rei Chen ^a,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; HEAT SHOCK PROTEIN 72; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; RECOMBINANT PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME DEGRADATION; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SEPSIS; TUNEL ASSAY; ANIMAL; COMPLICATION; DRUG EFFECTS; HUMAN; LIVER DISEASES; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; HSP72 HEAT-SHOCK PROTEINS; HUMANS; LIVER DISEASES; MALE; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SEPSIS;

EID: 84937010610     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/508101     Document Type: Article

References (47)

1. R. Stone, "Search for sepsis drugs goes on despite past failures," Science, vol. 264, no. 5157, pp. 365-367, 1994.
2. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, "The epidemiology of sepsis in the United States from 1979 through 2000," The New England Journal of Medicine, vol. 348, no. 16, pp. 1546-1554, 2003.
3. C. T. Esmon, K. Fukudome, T. Mather et al., "Inflammation, sepsis, and coagulation," Haematologica, vol. 84, pp. 254-259, 1999.
4. J. Jacobi, "Pathophysiology of sepsis," American Journal of Health-System Pharmacy, vol. 59, supplement 1, pp. S3-S8, 2002.
5. M. G. Jeschke, H. Rensing, D. Kleinet al., "Insulinprevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats," Journal of Hepatology, vol. 42, no. 6, pp. 870-879, 2005.
6. J. F. Dhainaut, N. Marin, A. Mignon, and C. Vinsonneau, "Hepatic response to sepsis: interaction between coagulation and inflammatory processes," Critical Care Medicine, vol. 29, no. 7, supplement, pp. S42-S47, 2001.
7. J. Yan, S. Li, and S. Li, "The role of the liver in sepsis," International Reviews of Immunology, vol. 33, no. 6, pp. 498-510, 2014.
8. H. Zhang, W. Wang, H. Fang et al., "GSK-3beta inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis," Mediators of Inflammation, vol. 2014, Article ID 629507, 10 pages, 2014.
9. H.-W. Chen, C. Hsu, S.-I. Lue, and R.-C. Yang, "Attenuation of sepsis-induced apoptosis by heat shock pretreatment in rats," Cell Stress and Chaperones, vol. 5, no. 3, pp. 188-195, 2000.
10. B. Jiang, P. Liang, G. Deng, Z. Tu, M. Liu, and X. Xiao, "Increased stability of Bcl-2 in HSP70-mediated protection against apoptosis induced by oxidative stress," Cell Stress and Chaperones, vol. 16, no. 2, pp. 143-152, 2011.
11. W. van Molle, B. Wielockx, T. Mahieu et al., "HSP70 protects against TNF-induced lethal inflammatory shock," Immunity, vol. 16, no. 5, pp. 685-695, 2002.
12. M. A. Yenari, J. Liu, Z. Zheng, Z. S. Vexler, J. E. Lee, and R. G. Giffard, "Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection," Annals of the New York Academy of Sciences, vol. 1053, pp. 74-83, 2005.
13. A. R. Taylor, M. B. Robinson, D. J. Gifondorwa, M. Tytell, and C. E. Milligan, "Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases," Developmental Neurobiology, vol. 67, no. 13, pp. 1815-1829, 2007.
14. A. H. Broquet, G. Thomas, J. Masliah, G. Trugnan, and M. Bachelet, "Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlateswith itsmembrane delivery and release," The Journal of Biological Chemistry, vol. 278, no. 24, pp. 21601-21606, 2003.
15. A. Clayton, A. Turkes, H. Navabi, M. D. Mason, and Z. Tabi, "Induction of heat shock proteins in B-cell exosomes," Journal of Cell Science, vol. 118, no. 16, pp. 3631-3638, 2005.
16. R. Njemini, M. Lambert, C. Demanet, and T. Mets, "Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assay," Scandinavian Journal of Immunology, vol. 58, no. 6, pp. 664-669, 2003.
17. M. J. Oglesbee, A. V. Herdman, G. G. Passmore, and W. H. Hoffman, "Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein," Clinical Biochemistry, vol. 38, no. 10, pp. 900-904, 2005.
18. J. G. Hecker and M. McGarvey, "Heat shock proteins as biomarkers for the rapid detection of brain and spinal cord ischemia: a review and comparison to other methods of detection in thoracic aneurysm repair," Cell Stress & Chaperones, vol. 16, no. 2, pp. 119-131, 2011.
19. J.-F. Pittet, H. Lee, D. Morabito, M. B. Howard, W. J. Welch, and R. C. Mackersie, "Serum levels of Hsp 72 measured early after trauma correlate with survival," The Journal of Trauma-Injury, Infection and Critical Care, vol. 52, no. 4, pp. 611-617, 2002.
20. D. S. Wheeler, L. E. Fisher Jr., J. D. Catravas, B. R. Jacobs, J. A. Carcillo, and H. R. Wong, "Extracellular hsp70 levels in children with septic shock," Pediatric Critical Care Medicine, vol. 6, no. 3, pp. 308-311, 2005.
21. T. R. Ziegler, L. G. Ogden, K. D. Singleton et al., "Parenteral glutamine increases serum heat shock protein 70 in critically ill patients," Intensive Care Medicine, vol. 31, no. 8, pp. 1079-1086, 2005.
22. S. Genth-Zotz, A. P. Bolger, P.R. Kalra et al., "Heat shockprotein 70 in patients with chronic heart failure: relation to disease severity and survival," International Journal of Cardiology, vol. 96, no. 3, pp. 397-401, 2004.
23. G. A. Kustanova, A. N. Murashev, V. L. Karpov et al., "Exogenous heat shock protein 70 mediates sepsis manifestations and decreases the mortality rate in rats," Cell Stress & Chaperones, vol. 11, no. 3, pp. 276-286, 2006.
24. X. Luo, L. Tao, P. Lin, X. Mo, and H. Chen, "Extracellular heat shock protein 72 protects schwann cells from hydrogen peroxide-induced apoptosis," Journal of Neuroscience Research, vol. 90, no. 6, pp. 1261-1269, 2012.
25. X. Luo, X. Zuo, X. Mo, Y. Zhou, and X. Xiao, "Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice," Inflammation, vol. 34, no. 5, pp. 432-439, 2011.
26. J. H. Hsu, R. C. Yang, S. J. Lin et al., "Exogenous heat shock cognate protein 70 pretreatment attenuates cardiac and hepatic dysfunction with associated anti-inflammatory responses in experimental septic shock," Shock, vol. 42, no. 6, pp. 540-547, 2014.
27. S. Takemoto, M. Nishikawa, and Y. Takakura, "Pharmacokinetic and tissue distribution mechanism of mouse recombinant heat shock protein 70 in mice," Pharmaceutical Research, vol. 22, no. 3, pp. 419-426, 2005.
28. M. S. Kocher, J. R. Steadman, K. K. Briggs, W. I. Sterett, and R. J. Hawkins, "Relationships between objective assessment of ligament stability and subjective assessment of symptoms and function after anterior cruciate ligament reconstruction," The American Journal of Sports Medicine, vol. 32, no. 3, pp. 629-634, 2004.
29. K. A. Wichterman, A. E. Baue, and I. H. Chaudry, "Sepsis and septic shock: a review of laboratorymodels and a proposal," The Journal of Surgical Research, vol. 29, no. 2, pp. 189-201, 1980.
30. L.-J. Huang, H.-P. Dong, I.-C. Chuang, M.-S. Liu, and R.-C. Yang, "Attenuation ofmitochondrial unfolded protein response is associated with hepatic dysfunction in septic rats," Shock, vol. 38, no. 6, pp. 642-648, 2012.
31. M. A. Chase, D. S. Wheeler, K. M. Lierl, V. S. Hughes, H. R. Wong, and K. Page, "Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism," The Journal of Immunology, vol. 179, no. 9, pp. 6318-6324, 2007.
32. H. Spapen, "Liver perfusion in sepsis, septic shock, and multiorgan failure," Anatomical Record, vol. 291, no. 6, pp. 714-720, 2008.
33. A. Liu, W. Wang, H. Fang et al., "Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice," European Journal of Pharmacology, vol. 748, pp. 45-53, 2015.
34. E. Rozhkova, M. Yurinskaya, O. Zatsepina et al., "Exogenous mammalian extracellular HSP70 reduces endotoxin manifestations at the cellular and organismlevels," Annals of the New York Academy of Sciences, vol. 1197, pp. 94-107, 2010.
35. M. Vinokurov, V. Ostrov, M. Yurinskaya et al., "Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levels," Cell Stress & Chaperones, vol. 17, no. 1, pp. 89-101, 2012.
36. H. Kobashi, J. Toshimori, and K. Yamamoto, "Sepsis-associated liver injury: incidence, classification and the clinical significance," Hepatology Research, vol. 43, no. 3, pp. 255-266, 2013.
37. C. Oberholzer, A. Oberholzer, M. Clare-Salzler, and L. L. Moldawer, "Apoptosis in sepsis: a new target for therapeutic exploration," The FASEB Journal, vol. 15, no. 6, pp. 879-892, 2001.
38. R. S. Hotchkiss, K.W. Tinsley, P. E. Swanson et al., "Prevention of lymphocyte cell death in sepsis improves survival in mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 25, pp. 14541-14546, 1999.
39. R. S. Hotchkiss, P. E. Swanson, C. M. Knudson et al., "Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis," Journal of Immunology, vol. 162, no. 7, pp. 4148-4156, 1999.
40. D. T. Chao and S. J. Korsmeyer, "BCL-2 family: regulators of cell death," Annual Review of Immunology, vol. 16, pp. 395-419, 1998.
41. S. Zinkel, A. Gross, and E. Yang, "BCL2 family in DNA damage and cell cycle control," Cell Death and Differentiation, vol. 13, no. 8, pp. 1351-1359, 2006.
42. G. Jia, Q. Wang, R. Wang, and et al, "Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway," Onco Targets and Therapy, vol. 8, pp. 303-2011, 2015.
43. G. Heimlich, A. D. McKinnon, K. Bernardo et al., "Bax-induced cytochrome c release frommitochondria depends on α-helices- 5 and -6," The Biochemical Journal, vol. 378, no. 1, pp. 247-255, 2004.
44. B. Mignotte and J.-L. Vayssiere, "Mitochondria and apoptosis," European Journal of Biochemistry, vol. 252, no. 1, pp. 1-15, 1998.
45. M. O. Hengartner, "The biochemistry of apoptosis," Nature, vol. 407, no. 6805, pp. 770-776, 2000.
46. S.-Y. Sun, N. Hail Jr., and R. Lotan, "Apoptosis as a novel target for cancer chemoprevention," Journal of the National Cancer Institute, vol. 96, no. 9, pp. 662-672, 2004.
47. Y. Shi, "Mechanisms of caspase activation and inhibition during apoptosis," Molecular Cell, vol. 9, no. 3, pp. 459-470, 2002.